Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ABUS

Arbutus Biopharma Corporation

Healthcare | Biotechnology
$4.39 +0.07 (+1.62%) as of 2026-07-15 02:27 UTC
Market Cap$850M
Volume1.10M
EPS (TTM)$-0.17

Arbutus Biopharma Corporation (NASDAQ: ABUS) is a $850M biotechnology company trading at $4.39 (+1.6% today). Figures from SEC EDGAR and market feeds; updated 2026-07-15 02:27 UTC.

52-Week Range
Low $3.04High $5.10
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Key facts
Quote
Price$4.39
Change (1D)+0.07 (+1.62%)
Market cap$850M
Volume1.10M shares
52-week range$3.04 – $5.10
Valuation
EPS (TTM)$-0.17
Price/book11.10×
Returns
52-week return+44.4%
Revenue, margins & earnings
FY2021: net loss $76M on revenue $11M$11MFY2021FY2022: net loss $69M on revenue $39M$39MFY2022FY2023: net loss $73M on revenue $18M$18MFY2023FY2024: net loss $70M on revenue $6M$6MFY2024FY2025: net loss $34M on revenue $14M$14MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-06-10
  • 2026-06-10Sawhney RogerA78,800—
  • 2026-06-10Beardsley Robert AA78,800—
  • 2026-02-02Androski LindsayPresident and CEOA28,000—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • MORGAN STANLEY25,891,480$116.51M-3.0%
  • Two Seas Capital LP18,557,543$83.51M+47.4%
  • Whitefort Capital Management, LP14,930,885$67.19M+11.9%
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does Arbutus Biopharma Corporation do?

Arbutus Biopharma Corporation is a biotechnology company, listed on NASDAQ as ABUS.

What is ABUS's valuation?

ABUS trades at $4.39, as of 2026-07-15.

When did ABUS last file with the SEC?

Arbutus Biopharma Corporation's most recent SEC filing on record is a 8-K filed 2026-05-27. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-15 02:27 UTC. This page is also available as JSON at /api/data?ticker=ABUS and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ABUS and 3,500+ tickers.

Create a free account — keep ABUS
For your agent
GET /api/data?ticker=ABUS

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt